EP3291812
INJECTABLE DEPOT FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.5.2016EP published:
1.9.2021EP application number:
16790066.1
EPO information:
European Patent Register
Max expiry date:
4.5.2036
Title:
INJECTABLE DEPOT FORMULATIONS
Timeline
Today
5.5.2016EP application
1.9.2021EP Publication
Owner
Name:
EyePoint Pharmaceuticals US, Inc.Address:
400 Pleasant Street, Watertown, MA 02472, US
Inventor
Name:
ASHTON, PaulAddress:
Newton, MA 02460, US
Priority
Number:
201562157257 PDate:
5.5.2015Country:
US
Classification
Categories:
A61K 31/44, A61P 27/02, A61K 47/10, A61K 9/08